Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 138 Schemes (43.85%)
Foreign Institutions
Held by 350 Foreign Institutions (18.16%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3,516 Million
(Quarterly Results - Dec 2025)
Net Profit:
165 Million
Pharmaceuticals & Biotechnology
USD 23,433 Million (Mid Cap)
30.00
NA
0.00%
0.61
-999,999.00%
2.72






